A massive increase in the Covid-19 count for India as the country registered fresh cases of
2,47,417 on Wednesday.
It is 27.06 percent more than the number of new Covid-19 cases reported in the previous
total.
There are 5 488 verified instances of Omicron found in India. In entire Omicron instances in
India, 2,162 cases were discharged.
Maharashtra remains to have the most Omicron cases, which is 1367. 792 confirmed
Omicron incidents within Rajasthan had been recorded at 792.
Rajasthan is the second-highest amount in Omicron incidents of any state in India and is
closely followed by Delhi.
Up to 549 Omicron cases have been reported in Delhi, the capital of India, in the last few
days.
The positive rate for the day is currently at 13.11 percent; the weekly positive rate for
Covid-19 is presently at 10.8 percent. India’s active caseload is currently at 11,17,531.
A total of 84,825 recovery cases have been recorded over the last 24 hours, as per the
figures supplied from the Ministry of Health and Family Welfare.
The total number of recovered cases in India to 3,471,153,361. The current rate of
recovery in India currently stands at 95.59 percent.
A total of 54.61 million vaccine doses were administered as part of the Nationwide
Vaccination Drive. In addition, 69.73 crore Covid-19 tests have been conducted to date.
Latest Covid-19 Updates
The Union Health Secretary Rajesh Bhushan has written a letter to the chief secretaries
from all the states and Union Territories asking them to immediately take steps to ensure
the highest quality of oxygen for medical use in hospitals, ANI reported.
In his letter of 11 January, Bhushan stated that States and Union Territories should have a
buffer of medical oxygen for at least 48 hours in hospitals that provide in-patient care.
He is requesting that the pressure swing adsorption (PSA) plants and the availability of
oxygen concentrators.
Additionally, Bharat Biotech, which created COVAXIN, the first Indian indigenously
developed Covid-19 vaccine announced on it, demonstrated that COVAXIN could neutralize
the Omicron and Delta CoV-2 variants of SARS.
